Login / Signup

Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2).

Ingvild FarnesDyre KleiveCaroline S VerbekeLars AabakkenAart Issa-EpeMilada Cvancarova SmåstuenBjarte V FosbySvein DuelandPål-Dag LineKnut J Labori
Published in: BJS open (2024)
Resection rates and survival in patients with borderline resectable pancreatic cancer and locally advanced pancreatic cancer treated at a high-volume centre in a universal healthcare system compare well with those treated at international expert centres.Registration number: NCT04423731 (http://www.clinicaltrials.gov).
Keyphrases
  • locally advanced
  • rectal cancer
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • radiation therapy
  • phase ii study
  • metabolic syndrome
  • adipose tissue
  • big data
  • clinical trial
  • machine learning
  • data analysis